circulating tumor DNA (ctDNA)
Circulating tumor DNA (ctDNA) refers to small fragments of genetic material released into the bloodstream by cancer cells. These fragments carry mutations and changes specific to tumors. By analyzing ctDNA, doctors can gain valuable information about the presence of cancer, track its progression, and assess how effective treatments are. This non-invasive method provides insights into a patient’s cancer without needing invasive biopsies, making it a promising tool for early detection, monitoring therapies, and personalizing cancer treatment plans. Ultimately, ctDNA offers a modern approach to understanding and managing cancer more effectively.
Additional Insights
-
Circulating tumor DNA (ctDNA) refers to tiny fragments of DNA that are released into the bloodstream by cancer cells. These fragments can provide important information about the genetic makeup of a tumor. By analyzing ctDNA, doctors can monitor the presence and progression of cancer, assess how well treatment is working, and identify potential mutations that may influence treatment decisions. ctDNA testing is a non-invasive method and can help personalize cancer care, making it a promising tool in oncology for better understanding and managing the disease.